Ye V Parshina
7PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 08, 2025
[Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis].A N Boyko, V M Alifirova, Z A Goncharova
|Apr 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].A N Boyko, V M Alifirova, I G Lukashevich
|Aug 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].A N Boyko, V M Alifirova, I G Lukashevich
|Apr 21, 2023
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].A N Boyko, V M Alifirova, I G Lukashevich
|Feb 27, 2023
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results].A N Boyko, K Z Bakhtiyarova, O V Boyko
|Feb 17, 2022
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial].A N Boyko, O V Boyko, K Z Bakhtiyarova
Pageof 2
Frequent Collaborators
7 joint publications
A V Zinkina-Orikhan
7 joint publications
Yu N Linkova
7 joint publications
L G Zaslavsky
6 joint publications
N A Malkova
6 joint publications
I Ye Poverennova
6 joint publications
S A Sivertseva
6 joint publications
N A Totolyan
5 joint publications
Z A Goncharova
5 joint publications
S G Shchur
5 joint publications
F A Khabirov
